
About Maximore Pharma Private Limited
Data last updated:
Maximore Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2021PTC156508. Its GSTIN is 36AAPCM1361C1ZM (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sreedhar Kakumanu and Naresh Goda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.5 – 1 – 22 Plot No.22 Sector – 4 Block – E, Road No.31 Alkapoor Township Narsingi Hyderabad, Telangana, India – 500089.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.31 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹30.29 Lakh and EBITDA of -₹30.29 Lakh.
The company is associated with 1 brand: Maximorepharma.
Maximore Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0035544). For more details, the company can be reached via its website maximorepharma.com.
Company details
Recognitions & Rankings of Maximore Pharma
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0035544
Contact details
Maximore Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is maximorepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No.5 – 1 – 22 Plot No.22 Sector – 4 Block – E, Road No.31 Alkapoor Township Narsingi Hyderabad, Telangana, India – 500089
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maximore Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maximore Pharma operates one associated brand: Maximorepharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical products, formulations, and APIs for health and wellness needs. | maximorepharma.com |
Business activity
The main business activity of Maximore Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maximore Pharma Private Limited, buy the company report.
Financials of Maximore Pharma Private Limited
FY 2025 filings availableMaximore Pharma Private Limited reported revenue of ₹4.31 Lakh (down 55% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 55% in the latest year. EBITDA fell 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹30.29 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹30.29 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Maximore Pharma Private Limited, buy the company report.
Board of directors of Maximore Pharma Private Limited
Maximore Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreedhar Kakumanu Also directs: Maximore Pharma Future LLP, Janagam Tea Pulses Private Limited, Maximore Builders Private Limited and 2 more | Director | 29 Oct 2021 | 4 Years 11 Months | Current |
| Naresh Goda | Director | 29 Oct 2021 | 4 Years 11 Months | Current |
Auditor
Maximore Pharma Private Limited is audited by Siva Sankar & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Siva Sankar & Associates | FY 2023 | 013648S |
Shareholding
The shareholding of Maximore Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Maximore Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maximore Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maximore Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maximore Pharma Private Limited has 1 active EPFO establishment as of Mar 22, 2024.
GST
Maximore Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCM1361C1ZM | Telangana | Active | 22 Nov 2021 |
To see the full GST registrations and return filing status of Maximore Pharma Private Limited, buy the company report.
Recent activity
Maximore Pharma Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Godishela Vijay Sai Goud ceased to be Additional Director on 27 Mar 2024.
Frequently asked questions
Maximore Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 October 2021 (5+ years old) and is registered under CIN U24239TG2021PTC156508.
Maximore Pharma has 2 current directors:
- Sreedhar Kakumanu - Director
- Naresh Goda - Director
The latest financial statements of Maximore Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Maximore Pharma is 36AAPCM1361C1ZM, registered in Telangana.
The CIN (Corporate Identification Number) of Maximore Pharma is U24239TG2021PTC156508. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maximore Pharma was incorporated on 29 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Godishela Vijay Sai Goud ceased to be Additional Director on 27 Mar 2024. Aruna Yerramshetty ceased to be Additional Director on 29 Sep 2023. Kunti Bheemesh War Yadav ceased to be Director on 29 Jun 2022. Maximore Pharma has 5 board changes on record in total.
Yes, Maximore Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Maximore Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0035544).
Maximore Pharma can be reached through the website maximorepharma.com. Its registered office is in Hyderabad, Telangana, India.